TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Svea Vaccin AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
169,152
|
233,868
|
109,039 |
Financial expenses |
0
|
41
|
20 |
Earnings before taxes |
18,750
|
51,835
|
5,512 |
EBITDA |
18,033
|
52,110
|
5,932 |
Total assets |
37,262
|
66,383
|
30,483 |
Current assets |
33,969
|
63,610
|
27,577 |
Current liabilities |
20,763
|
24,826
|
26,051 |
Equity capital |
15,509
|
41,557
|
4,432 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
65
|
80
|
49 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
41.6%
|
62.6%
|
14.5% |
Turnover per employee |
2,602
|
2,923
|
2,225 |
Profit as a percentage of turnover |
11.1%
|
22.2%
|
5.1% |
Return on assets (ROA) |
50.3%
|
78.1%
|
18.1% |
Current ratio |
163.6%
|
256.2%
|
105.9% |
Return on equity (ROE) |
120.9%
|
124.7%
|
124.4% |
Change turnover |
-64,716
|
124,829
|
-20,923 |
Change turnover % |
-28%
|
114%
|
-16% |
Chg. No. of employees |
-15
|
31
|
2 |
Chg. No. of employees % |
-19%
|
63%
|
4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.